Literature DB >> 16849273

Simple models for containment of a pandemic.

Julien Arino1, Fred Brauer, P van den Driessche, James Watmough, Jianhong Wu.   

Abstract

Stochastic simulations of network models have become the standard approach to studying epidemics. We show that many of the predictions of these models can also be obtained from simple classical deterministic compartmental models. We suggest that simple models may be a better way to plan for a threatening pandemic with location and parameters as yet unknown, reserving more detailed network models for disease outbreaks already underway in localities where the social networks are well identified.We formulate compartmental models to describe outbreaks of influenza and attempt to manage a disease outbreak by vaccination or antiviral treatment. The models give an important prediction that may not have been noticed in other models, namely that the number of doses of antiviral treatment required is extremely sensitive to the number of initial infectives. This suggests that the actual number of doses needed cannot be estimated with any degree of reliability. The model is applicable to pre-epidemic vaccination, such as annual vaccination programs in anticipation of an 'ordinary' influenza outbreak with limited drift, and as a combination of treatment both before and during an epidemic.

Mesh:

Substances:

Year:  2006        PMID: 16849273      PMCID: PMC1578753          DOI: 10.1098/rsif.2006.0112

Source DB:  PubMed          Journal:  J R Soc Interface        ISSN: 1742-5662            Impact factor:   4.118


  8 in total

1.  Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission.

Authors:  P van den Driessche; James Watmough
Journal:  Math Biosci       Date:  2002 Nov-Dec       Impact factor: 2.144

2.  Some simple epidemic models.

Authors:  Fred Brauer
Journal:  Math Biosci Eng       Date:  2006-01       Impact factor: 2.080

3.  Modelling strategies for controlling SARS outbreaks.

Authors:  Abba B Gumel; Shigui Ruan; Troy Day; James Watmough; Fred Brauer; P van den Driessche; Dave Gabrielson; Chris Bowman; Murray E Alexander; Sten Ardal; Jianhong Wu; Beni M Sahai
Journal:  Proc Biol Sci       Date:  2004-11-07       Impact factor: 5.349

4.  Strategies for containing an emerging influenza pandemic in Southeast Asia.

Authors:  Neil M Ferguson; Derek A T Cummings; Simon Cauchemez; Christophe Fraser; Steven Riley; Aronrag Meeyai; Sopon Iamsirithaworn; Donald S Burke
Journal:  Nature       Date:  2005-08-03       Impact factor: 49.962

5.  Containing pandemic influenza at the source.

Authors:  Ira M Longini; Azhar Nizam; Shufu Xu; Kumnuan Ungchusak; Wanna Hanshaoworakul; Derek A T Cummings; M Elizabeth Halloran
Journal:  Science       Date:  2005-08-03       Impact factor: 47.728

6.  Containing pandemic influenza with antiviral agents.

Authors:  Ira M Longini; M Elizabeth Halloran; Azhar Nizam; Yang Yang
Journal:  Am J Epidemiol       Date:  2004-04-01       Impact factor: 4.897

7.  Potential impact of antiviral drug use during influenza pandemic.

Authors:  Raymond Gani; Helen Hughes; Douglas Fleming; Thomas Griffin; Jolyon Medlock; Steve Leach
Journal:  Emerg Infect Dis       Date:  2005-09       Impact factor: 6.883

8.  Cost-benefit of stockpiling drugs for influenza pandemic.

Authors:  Ran D Balicer; Michael Huerta; Nadav Davidovitch; Itamar Grotto
Journal:  Emerg Infect Dis       Date:  2005-08       Impact factor: 6.883

  8 in total
  42 in total

1.  Comparative estimation of the reproduction number for pandemic influenza from daily case notification data.

Authors:  Gerardo Chowell; Hiroshi Nishiura; Luís M A Bettencourt
Journal:  J R Soc Interface       Date:  2007-02-22       Impact factor: 4.118

2.  Assessing the role of basic control measures, antivirals and vaccine in curtailing pandemic influenza: scenarios for the US, UK and the Netherlands.

Authors:  M Nuño; G Chowell; A B Gumel
Journal:  J R Soc Interface       Date:  2007-06-22       Impact factor: 4.118

3.  The impact of prophylaxis of healthcare workers on influenza pandemic burden.

Authors:  Michael Gardam; Dong Liang; Seyed M Moghadas; Jianhong Wu; Qingling Zeng; Huaiping Zhu
Journal:  J R Soc Interface       Date:  2007-08-22       Impact factor: 4.118

4.  Emergence of drug resistance: implications for antiviral control of pandemic influenza.

Authors:  Murray E Alexander; Christopher S Bowman; Zhilan Feng; Michael Gardam; Seyed M Moghadas; Gergely Röst; Jianhong Wu; Ping Yan
Journal:  Proc Biol Sci       Date:  2007-07-22       Impact factor: 5.349

5.  Antiviral treatment for the control of pandemic influenza: some logistical constraints.

Authors:  N Arinaminpathy; A R McLean
Journal:  J R Soc Interface       Date:  2008-05-06       Impact factor: 4.118

6.  Effectiveness and cost-effectiveness of expanded antiviral prophylaxis and adjuvanted vaccination strategies for an influenza A (H5N1) pandemic.

Authors:  Nayer Khazeni; David W Hutton; Alan M Garber; Douglas K Owens
Journal:  Ann Intern Med       Date:  2009-12-15       Impact factor: 25.391

7.  Strategies for the use of oseltamivir and zanamivir during pandemic outbreaks.

Authors:  Elsa Hansen; Troy Day; Julien Arino; Jianhong Wu; Seyed M Moghadas
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

8.  Effectiveness and cost-effectiveness of vaccination against pandemic influenza (H1N1) 2009.

Authors:  Nayer Khazeni; David W Hutton; Alan M Garber; Nathaniel Hupert; Douglas K Owens
Journal:  Ann Intern Med       Date:  2009-12-15       Impact factor: 25.391

9.  One versus two doses: What is the best use of vaccine in an influenza pandemic?

Authors:  Laura Matrajt; Tom Britton; M Elizabeth Halloran; Ira M Longini
Journal:  Epidemics       Date:  2015-06-22       Impact factor: 4.396

10.  Evaluation of targeted influenza vaccination strategies via population modeling.

Authors:  John Glasser; Denis Taneri; Zhilan Feng; Jen-Hsiang Chuang; Peet Tüll; William Thompson; Mary Mason McCauley; James Alexander
Journal:  PLoS One       Date:  2010-09-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.